产品名称 | NebuSelect™ Recombinant SARS-CoV-2 Spike RBD (Omicron XBB), His-tag |
---|---|
目录号 | NBL-241493 |
别名 | Spike RBD (Omicron XBB) |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | QHD43416.1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241493-100ug | 100ug | Inquire | Inquire | |
NBL-241493-1mg | 1mg | Inquire | Inquire | |
NBL-241493-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant SARS-CoV-2 Spike RBD (Omicron XBB), His-tag
Catalog#:
NBL-241493
Description:
NebuSelect™ Recombinant SARS-CoV-2 Spike RBD (Omicron XBB), His-tag(Cat#NBL-241493) is expressed in HEK293 with His tag at the C-Terminus.It contains Arg319-Phe541(G339H, R346T, L368I, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, V445P, G446S, N460K, S477N, T478K, E484A, F486S, F490S, Q498R, N501Y, Y505H).
Species:
SARS-COV-2
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 26.21 kDa. Due to glycosylation, the protein migrates to 35-45 kDa based on Bis-Tris PAGE result.
Target Name:
Spike RBD (Omicron XBB)
Target Information:
The ongoing coronavirus disease 2019 (COVID-19) pandemic has prioritized the development of small-animal models for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The resulting mouse-adapted strain at passage 6 (called MASCp6) showed increased infectivity in mouse lung and led to interstitial pneumonia and inflammatory responses in both young and aged mice after intranasal inoculation. Deep sequencing revealed a panel of adaptive mutations potentially associated with the increased virulence. In particular, the N501Y mutation is located at the receptor binding domain (RBD) of the spike protein.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.